Detalhe da pesquisa
1.
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Lancet
; 403(10429): 838-849, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364839
2.
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023.
Ann Rheum Dis
; 83(4): 409-416, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123338
3.
Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases.
Rheumatology (Oxford)
; 63(2): 298-308, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624925
4.
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures.
Rheumatology (Oxford)
; 63(4): 1015-1021, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37389432
5.
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study.
BMC Cancer
; 24(1): 733, 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38877461
6.
Role of IFN-α in Rheumatoid Arthritis.
Curr Rheumatol Rep
; 26(2): 37-52, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051494
7.
Characterization of age-associated B cells in early drug-naïve rheumatoid arthritis patients.
Immunology
; 168(4): 640-653, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36281956
8.
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR).
Eur Respir J
; 61(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229048
9.
Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis.
Ann Rheum Dis
; 82(5): 611-620, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810200
10.
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022.
Ann Rheum Dis
; 82(5): 594-598, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702529
11.
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 82(1): 65-73, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551063
12.
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Ann Rheum Dis
; 82(6): 773-787, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953263
13.
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis.
Rheumatology (Oxford)
; 62(6): 2090-2097, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190343
14.
Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacy.
Rheumatology (Oxford)
; 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37930878
15.
Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study.
Rheumatol Int
; 43(8): 1459-1465, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227468
16.
CAR T Cells - A New Horizon for Autoimmunity?
N Engl J Med
; 390(8): 758-759, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381679
17.
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.
Ann Rheum Dis
; 2022 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680389
18.
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19.
Ann Rheum Dis
; 81(1): 34-40, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620584
19.
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update.
Ann Rheum Dis
; 81(12): 1628-1639, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197264
20.
The role of comorbidities alongside patient and disease characteristics in long-term disease activity in RA using UK inception cohort data.
Rheumatology (Oxford)
; 61(11): 4297-4304, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35258566